PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Sadowski, M.* ; Thompson, M.* ; Mefford, J.* ; Haldar, T.* ; Oni-Orisan, A.* ; Border, R.* ; Pazokitoroudi, A.* ; Cai, N. ; Ayroles, J.F.* ; Sankararaman, S.* ; Dahl, A.W.* ; Zaitlen, N.*

Characterizing the genetic architecture of drug response using gene-context interaction methods.

Cell Genom. 4:100722 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Identifying factors that affect treatment response is a central objective of clinical research, yet the role of common genetic variation remains largely unknown. Here, we develop a framework to study the genetic architecture of response to commonly prescribed drugs in large biobanks. We quantify treatment response heritability for statins, metformin, warfarin, and methotrexate in the UK Biobank. We find that genetic variation modifies the primary effect of statins on LDL cholesterol (9% heritable) as well as their side effects on hemoglobin A1c and blood glucose (10% and 11% heritable, respectively). We identify dozens of genes that modify drug response, which we replicate in a retrospective pharmacogenomic study. Finally, we find that polygenic score (PGS) accuracy varies up to 2-fold depending on treatment status, showing that standard PGSs are likely to underperform in clinical contexts.
Impact Factor
Scopus SNIP
Altmetric
11.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Gene-environment Interactions ; Genetic Heterogeneity ; Genetic Testing ; Heritability ; Heteroskedasticity ; Personalized Medicine ; Pharmacogenomics; Genome-wide Association; Environment Interactions; Cardiovascular-disease; Polygenic-score; Uk Biobank; Metformin; Therapy; Risk; Efficacy; Genotype
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 2666-979X
e-ISSN 2666-979X
Zeitschrift Cell Genomics
Quellenangaben Band: 4, Heft: 12, Seiten: , Artikelnummer: 100722 Supplement: ,
Verlag Elsevier
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Pioneer Campus (HPC)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Pioneer Campus
PSP-Element(e) G-510007-001
Förderungen National Institutes of Health
Chan Zuckerberg Initiative grant
DOI 10.1016/j.xgen.2024.100722
WOS ID 001385667700001
Scopus ID 85211336905
PubMed ID 39637863
Erfassungsdatum 2024-12-10
[➜Korrektur melden]